# ClinicalTrials.gov record NCT00004635

> PeptideScanner retained ClinicalTrials.gov record NCT00004635 at 2026-07-30T21:11:31.039Z. Its registry update date was 2018-05-22, and PeptideScanner's reviewed identity mapping was leuprolide.

- Evidence object: `story:clinicaltrials-gov-nct00004635-leuprolide:v1`
- Evidence domain: Clinical trials
- Date in source: 2018-05-22
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00004635-leuprolide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00004635-leuprolide-v1.json
- Content SHA-256: `7ba62ae2192d1ad8b80a52473414bdd049c982d848a33db3b99a9d42c555eb51`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00004635 ([`ctg-observation-nct00004635-2018-05-22-1737802bd24f`](#source-ctg-observation-nct00004635-2018-05-22-1737802bd24f))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00004635 at 2026-07-30T21:11:31.039Z. Its registry update date was 2018-05-22, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00004635-2018-05-22-1737802bd24f`](#source-ctg-observation-nct00004635-2018-05-22-1737802bd24f))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00004635 at 2026-07-30T21:11:31.039Z. Its registry update date was 2018-05-22, and PeptideScanner's reviewed identity mapping was leuprolide. ([`ctg-observation-nct00004635-2018-05-22-1737802bd24f`](#source-ctg-observation-nct00004635-2018-05-22-1737802bd24f))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00004635-2018-05-22-1737802bd24f`](#source-ctg-observation-nct00004635-2018-05-22-1737802bd24f))

## Sources

<a id="source-ctg-observation-nct00004635-2018-05-22-1737802bd24f"></a>
- **ClinicalTrials.gov record NCT00004635 · retained source version 2018-05-22:1737802bd24f6ec834ec0a2853d8aab5386187451e747b822fbbf23ebe96eec3** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00004635) (`ctg-observation-nct00004635-2018-05-22-1737802bd24f`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00004635." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00004635-leuprolide-v1.json SHA-256: 7ba62ae2192d1ad8b80a52473414bdd049c982d848a33db3b99a9d42c555eb51.